SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0287
Expires:	February 28, 2011
Estimated average burden
hours per response		0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

PULWER EDWARD

(Last)

(First)

(Middle)

C/O VIASYS HEALTHCARE INC.

227 WASHINGTON STREET, SUITE 200

(Street)

CONSHOHOCKEN

19428

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
VIASYS HEALTHCARE INC [ VAS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/28/2007

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								12,194	D
Common Stock	06/28/2007		J	V	404	A	$23.65	12,598	D
Common Stock	06/28/2007		M		7,500	A	$27.65	20,098	D
Common Stock	06/28/2007		M		27,550	A	$28.77	47,648	D
Common Stock	06/28/2007		M		2,500	A	$14.23	50,148	D
Common Stock	06/28/2007		M		25,000	A	$16.37	75,148	D
Common Stock	06/28/2007		M		22,000	A	$13.99	97,148	D
Common Stock	06/28/2007		M		50,000	A	$16.35	147,148	D
Common Stock	06/28/2007		F		60,116	D	$42.75	87,032	D
Common Stock	06/28/2007		D		74,838 ^{( 2 )}	D	$42.75	12,194	D
Common Stock	06/28/2007		D		12,194 ^{( 3 )}	D	$42.75	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$14.23	06/28/2007		M			2,500	^{( 4 )}	09/24/2011	Common Stock	2,500	^{( 5 )}	0	D
Stock Option (Right to Buy)	$16.37	06/28/2007		M			25,000	^{( 4 )}	11/22/2012	Common Stock	25,000	^{( 5 )}	0	D
Stock Option (Right to Buy)	$13.99	06/28/2007		M			22,000	^{( 4 )}	02/13/2013	Common Stock	22,000	^{( 5 )}	0	D
Stock Option (Right to Buy)	$16.35	06/28/2007		M			33,330	^{( 4 )}	09/21/2014	Common Stock	33,330	^{( 5 )}	0	D
Stock Option (Right to Buy)	$27.65	06/28/2007		M			7,500	^{( 6 )}	01/25/2016	Common Stock	7,500	^{( 5 )}	0	D
Stock Option (Right to Buy)	$28.77	06/28/2007		M			27,550	^{( 6 )}	02/13/2017	Common Stock	27,550	^{( 5 )}	0	D
Stock Option (Right to Buy)	$16.35	06/28/2007		M			16,670	^{( 6 )}	09/21/2014	Common Stock	16,670	^{( 5 )}	0	D

Explanation of Responses:

1. Constitutes shares acquired under the issuers Employee Stock Purchase Plan on June 27, 2007. This acquisition was made pursuant to Rule 16b-3(c).

2. Disposed of pursuant to the Merger (as defined in note 3 below) in exchange for $42.75 per share.

3. Under the terms of an Agreement and Plan of Merger, dated as of May 11, 2007, (the "Merger Agreement") among Cardinal Health Inc. ("Cardinal Health"), an Ohio corporation, Eagle Merger Corp., a Delaware corporation and a wholly-owned subsidiary of Cardinal Health (the "Offeror") and the Issuer, all restricted stock units held by the reporting person have been cancelled by the Issuer, and the reporting person is receiving, in lieu thereof, an amount equal to $42.75 (equivalent to the amount per share to be received by Company shareholders upon the merger (the "Merger") of the Offeror into the Company pursuant to the terms of the Merger Agreement) times the number of restricted stock units held by the reporting person. Following the Merger, the Issuer became a wholly-owned subsidiary of Cardinal Health.

4. These options are immediately exercisable.

5. The exercise price of the option is disclosed in Table II Column 2.

6. Under the terms of the Merger Agreement, all outstanding unvested options to purchase Issuer common stock vested immediately prior to the Offeror's initial acceptance for payment of shares of Issuer common stock pursuant to a tender offer by the Offeror for all outstanding shares of Issuer Common Stock. Such acceptance occurred on June 21, 2007.

Remarks:

	By: Catherine A. Petko Limited Power of Attorney For: Edward Pulwer	07/05/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.